Observing kidney stone patients undergoing endoscopic surgery
Retrospective and Prospective Study of Patients Suffering From Nephrolithiasis Undergoing Surgery Using a Minimally Invasive Endoscopic Approach.
This study looks at kidney stone patients who are having a special type of surgery to see how their genes and stone types affect their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, Lombardy) |
| Trial ID | NCT06163313 on ClinicalTrials.gov |
What this trial studies
This study collects clinical data from patients suffering from nephrolithiasis who undergo minimally invasive endoscopic surgery. It aims to correlate phenotypic and genotypic aspects of patients with their stone pathology, assessing the effectiveness of the endoscopic approach in treating kidney stones while minimizing operative complications. Data will be gathered before and after surgery, including details about the stones and surgical instruments used, to enhance therapeutic strategies and reduce recurrence risks through genetic analysis.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older suffering from kidney stones or tumors of the upper excretory tract.
Not a fit: Patients under 18 years old or those with mental or physical disabilities that hinder their ability to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for kidney stones and a reduction in recurrence rates.
How similar studies have performed: Other studies have shown success with similar endoscopic approaches for treating kidney stones, indicating a promising avenue for this research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects suffering from kidney stones or tumors of the upper excretory tract \>= 18 years * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Where this trial is running
Milan, Lombardy
- IRCCS Ospedale San Raffaele — Milan, Lombardy, Italy (Recruiting)
Study contacts
- Principal investigator: Andrea Salonia, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Andrea Salonia, MD
- Email: salonia.andrea@hsr.it
- Phone: 02 2643 5661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.